Akorn (AKRX)
Akorn Capital Expenditures: 3.974M
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
AKRX Capital Expenditures Rankings
| Overall | 42nd percentile | 2547 of 4450 |
| Sector | 25th percentile | 377 of 507 in Healthcare |
| Industry | 14th percentile | 12 of 14 in Drugs - Generic |
AKRX Capital Expenditures Range, Past 5 Years
| Minimum | 0.225M | Dec 2009 |
| Maximum | 4.725M | Dec 2011 |
| Average | 1.462M |
About Capex
Capital expenditures are a line item from a company's statement of cash flows (click "Learn More" below for details).
Capex (short for capital expenditures) are incurred when a business spends money to purchase fixed assets or to add value to an existing fixed asset. In accounting, a capital expenditures are added to an asset account, thus increasing the value of the asset.
Examples of capital expenditures include the purchase of a new manufacturing plant, investment in server farms for tech companies, or other purchases of assets expected to help the company earn profits in the future.
Unlike other investments like research and development and marketing spending, capital expenditures are not immediately expensed. Rather, property, plant and equipment acquired using capital expenditures are usually expensed over time through the use of depreciation.
Learn More
You may also be interested in these AKRX related companies
AKRX News
$AKRX holding up nicely,still a great looking chart.just cleared $13 buy point should form another base
about 3 days ago by Freshcharts
about 3 days ago by Freshcharts
$AKRX http://stks.co/3wn4 Tried to breakout again after yesterday's breakout but failed to close near the highs. On watch.
about 4 days ago by ACInvestorBlog
about 4 days ago by ACInvestorBlog
Movers: $GENE GeneTec3.68+1.27 $NLNK NewLinkGen11.88 $AKRX Akorn13.53 $RAD RiteAid1.31 $RDN Radian2.55 $IDNG IndEng2.89 http://stks.co/3wSZ
about 5 days ago by InvestorsGuru
about 5 days ago by InvestorsGuru
$AKRX Akorn price target raised to $16 from $14 at Piper Jaffray http://stks.co/3tV2
about 9 days ago by DrNick
about 9 days ago by DrNick
Bought some $AKRX today into the close. Will quadruple if it trades above 13.
about 10 days ago by vjtweet
about 10 days ago by vjtweet
3 Stocks Hit 52-Week Highs http://stks.co/3pyO My story via @TheStreet $ALGT $CL $AKRX #52WeekHigh
about 12 days ago by azendrian
about 12 days ago by azendrian
Updated. B/O today, but a Shooting * is trying to form. $AKRX http://chart.ly/3pnm2x8
about 12 days ago by 1nvestor
about 12 days ago by 1nvestor
$sxci $wfm lookin good got some recent hods. $akrx holding 1.5% gains and looking for continuation
about 12 days ago by MrDayer
about 12 days ago by MrDayer
$AKRX Needham & Company Reaffirms Buy Rating on Akorn (AKRX) & increase in Target Price http://stks.co/3oif
about 13 days ago by DrNick
about 13 days ago by DrNick
Needham & Company Maintains a 'Buy' on Akorn (AKRX); New Product Outlook Affords Upward Bias
May 09, 7:51AM Street Insider
May 09, 7:51AM Street Insider
Akorn, Inc. Announces First Quarter 2012 Earnings Release and Conference Call Information
Apr 17, 4:48PM PR Newswire
Apr 17, 4:48PM PR Newswire
Needham & Company Maintains a 'Buy' on Akorn (AKRX); Strong Tailwinds Drive 4Q11 Top-Line Upside; Pipeline Looks Good
Mar 07, 7:30AM Street Insider
Mar 07, 7:30AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| AKRX | 13.70 | +0.11 | +0.81% | 1.302B |
| AKR | 22.34 | +0.09 | +0.40% | 955.26M |
| AKP | 15.28 | +0.15 | +1.00% | |
| AKO.A | 25.55 | -0.19 | -0.74% | 3.237B |
| AKAM | 29.31 | -0.09 | -0.31% | 5.211B |
| AJG | 34.94 | -0.20 | -0.57% | 4.101B |
| AMZN | 212.89 | -2.35 | -1.09% | 96.88B |
| AMX | 23.84 | -0.15 | -0.63% | 92.34B |
| AMWD | 16.57 | -0.18 | -1.07% | 237.95M |
| AMTD | 17.24 | +0.19 | +1.11% | 9.458B |
